comprehensive
Previous article:
Moonlake's readout produced a cash windfall. Risks remain
Next article: CDC advisory group OKs chikungunya vaccine
Next article: CDC advisory group OKs chikungunya vaccine
focus
entertainment
-
Beam Therapeutics to lay off 20% of its staff, re
2025-10-02 23:01 -
STAT Summit: Michael J. Fox on progress in Parkinson's research
2025-10-02 22:46 -
First Opinion Podcast: Long Covid needs a new approach
2025-10-02 22:21 -
Will Ozempic
2025-10-02 21:32 -
Are embryos people? Reproductive medicine's future depends on the answer
2025-10-02 21:11 -
Elisabeth Bik tackles the widespread issue of research misconduct
2025-10-02 21:04